Quickscribe.bc.ca

PDF Version
[Printer-friendly - ideal for printing entire document] VENEREAL DISEASE ACT TREATMENT
REGULATION 64/84 [Repealed March 31/09 by B.C.
Published by Quickscribe Services Ltd.
[includes B.C. Reg. 164/97 amendments] Important: Printing multiple copies of a statute or regulation for the purpose of distribution without the
written consent of Quickscribe Services Ltd. is strictly prohibited.
Quickscribe offers a convenient and economical updating service for those who wish to maintain a current B.C. Reg. 64/84 Go to http://www.quickscribe.bc.ca/TermsOfUse/ to view the Terms of Use. VENEREAL DISEASE ACT TREATMENT REGULATION 64/84 [Repealed March 31/09 by B.C. Reg. 18/2009] VENEREAL DISEASE ACT TREATMENT REGULATION 64/84
[Repealed March 31/09 by B.C. Reg. 18/2009]
[includes B.C. Reg. 164/97 amendments] [Provisions of the Venereal Disease Act, RSBC 1996, c. 475, relevant to the enactment of this regulation: section 1] In this regulation: "Act" means Venereal Disease Act;
"Canadian Guidelines" means the most current edition of the Canadian Guidelines for the
Treatment of Sexually Transmitted Diseases published by Health Canada.
[am. B.C. Reg. 164/97.] For the purposes of section 1 of the Act, adequate treatment is for venereal diseases discussed in the Canadian Guidelines, the treatment set out inthe Canadian Guidelines and any additional treatment an infected person is directedto take by his or her physician or a medical health officer, and for venereal diseases not discussed in the Canadian Guidelines, the treatment aninfected person is directed to take by his or her physician or a medical health officer.
[en. B.C. Reg. 164/97.] B.C. Reg. 64/84 Page 2 of 6 Quickscribe Services Ltd. VENEREAL DISEASE ACT TREATMENT REGULATION 64/84 [Repealed March 31/09 by B.C. Reg. 18/2009] Ampicillin 3.5 g or Aqueous procainepenicillin G 4.8 Mu 1.M. plus probenecid 1 g Tetracycline 500 mg 4times daily x 5 days As for urethral/cervical Aqueous procaine penicillin G 4.8 Mu1.M. plus probenecid 1 g Aqueous procaine penicillin G 4.8 Mu Tetracycline 500 mg 4 1.M. plus probenecid 1 g times daily x 5 days pelvic inflammatory disease As for urethral/cervical plus ampicillin 500 Tetracycline 500 mg po 4 mg 4 times daily x 10-14 days times daily x 10-14 days Crystalline penicillin G 16-20 Mu/day I.V.
Cefoxitin 2 g I.V. 8 hourly until improved to be followed by ampicillin until improved to 500 mg 4 times daily to complete a 10-14 be followed by tetracycline day treatment period 500 mg 4times daily to complete a10-14 day treatment period As for urethral/cervical plus ampicillin 500 mg 4 times daily x Tetracycline 500 mg 4 times daily x 10days disseminated gonococcal infection — bacteremia Crystalline penicillin G 12-16 Mu/day I.V. until improved to Cefoxitin 2 g I.V. 8 hourly be followed by ampicillin 500 mg 4 times daily to complete a until improved to be 7-10 day treatment period followed by tetracycline As for urethral/cervical plus ampicillin 500 mg 4 times daily x times daily to complete a 7-10 day treatment period neonates— ophthalmia Crystalline penicillin G 50,000 u/kg/day B.C. Reg. 64/84 Page 3 of 6 Quickscribe Services Ltd. VENEREAL DISEASE ACT TREATMENT REGULATION 64/84 [Repealed March 31/09 by B.C. Reg. 18/2009] I.V. in 2 doses x 7 days PLUSSaline irrigation Amoxicillin 50 kg plus probenecid 25 mg/ Spectinomycin 40 mg/kg Aqueous procaine penicillin G 100,000 u/kg I.M. stat plus probenecid (as above) Spectinomycin 2 g I.M.
Cefoxitin 2 g I.M. plus — cervical— rectal Cotrimoxazole* 9 tablets 4 times daily x 5 days* cotrimoxazole=sulfamethoxazole/trimethoprim All recent sexual contacts must be located, examined, cultured and offered therapy. All patients should return3 to 7 days after completion of therapy for re-evaluation to ensure efficacy of antimicrobial therapy and tohave follow-up cultures obtained from previously infected sites.
All cases must be reported to the local STD control authorities.
If incubating syphilis is a concern aqueous procaine penicillin G should be used. Ampicillin, amoxicillin andtetracycline may not be effective in aborting syphilis. Long acting tetracycline analogs, particularlydoxycycline, may be used in place of tetracycline.
The penicillins and probenecid are safe during pregnancy. Tetracycline and cotrimoxazole should be avoided.
In penicillin allergic patients, spectinomycin may be used although safety for use during human pregnancy hasnot yet been established. Erythromycin may be used in the same dosage as tetracycline but it is less effectiveand tests of cure are extremely important when this drug is used.
ORAL PENICILLIN AND LONG ACTING FORMS OF PENICILLIN (BENZATHINE PENICILLIN G)HAVE NO PLACE IN THE TREATMENT OF GONORRHEA.
Benzathine penicillin G 2.4 Mu I.M. at a single session B.C. Reg. 64/84 Page 4 of 6 Quickscribe Services Ltd. VENEREAL DISEASE ACT TREATMENT REGULATION 64/84 [Repealed March 31/09 by B.C. Reg. 18/2009] Tetracycline 500 mg 4 times daily x 15 days Aqueous procaine penicillin G 600,000 u I.M. daily x 8 days than 1 year'sduration.
Benzathine penicillin G 2.4 Mu I.M. weekly x 3 weeks Tetracycline 500 mg 4 times daily x 30 days Aqueous procaine penicillin G 600,000 uI.M. daily x 15 days Crystalline penicillin G 3-5 Mu I.V. 4hourly for at least 10 days Benzathine penicillin G 50,000 u/kgI.M.at a single session Crystalline penicillin G 25,000 u/kg I.V. twice daily x 10 All sexual contacts must be located, examined and treated especially when the index appropriate case issuffering from infectious syphilis.
Pregnant women with syphilis, who have not previously been treated, should receive penicillin in dosesappropriate to the stage of the disease. Retreatment during pregnancy is unnecessary unless there is clinical orserologic evidence of new infection. Syphilis serology should be periodically re-examined during pregnancy.
Erythromycin, in the same dosage as tetracycline, should only be used in patients allergic to both penicillinand tetracycline or in penicillin-allergic pregnant women. The efficacy of this regimen has not been wellestablished.
Examination of the cerebrospinal fluid is mandatory to establishing the diagnosis of neurosyphillis.
Individuals should be encouraged to return for repeat serology 3, 6 and 12 months following therapy.
Follow-up is particularly important in patients treated with antibiotics other than penicillin.
Erythromycin 500 mg 4 times dailyORCotrimoxazole* 160/800 mg twice dailyfor a minimum of 10 days or until ulcer B.C. Reg. 64/84 Page 5 of 6 Quickscribe Services Ltd. VENEREAL DISEASE ACT TREATMENT REGULATION 64/84 [Repealed March 31/09 by B.C. Reg. 18/2009] and/or lymph node is healed*trimethoprim/sulfamethoxazole [Provisions of the Venereal Disease Act, RSBC 1996, c. 475, relevant to the enactment of this regulation: B.C. Reg. 64/84 Page 6 of 6 Quickscribe Services Ltd.

Source: http://www.quickscribe.bc.ca/secure/pdfs/2837.pdf

Msds_cream_hardener2.pdf

Distributed in Australia by Orthotic & Prosthetic Centre Pty Ltd, Trading as OPC Health 151-159 Turner Street PORT MELBOURNE VIC 3207 T: 03 9681 9666 F: 03 9681 9366E: [email protected] OPC HEALTH ABN: 26 454 494 673 ACN: 005 863 525 SECTION 1 – Chemical Product and Company Identification